https://nl.marketscreener.com/koers/aandeel/2SEVENTY-BIO-INC-128358117/nieuws/Regeneron-Pharmaceuticals-Inc-NasdaqGS-REGN-heeft-de-overname-van-de-R-D-pijplijn-van-2seventy-b-46330255/?utm_source=telegram&utm_medium=social&utm_campaign=share